Published in Physician Law Weekly, February 8th, 2006
Johnston will be responsible for defining the company's FDA strategy and leading the legal and compliance functions.
"We are pleased to have an executive with Perry's experience and skill set joining the senior team," said Dirk Soenksen, CEO of Aperio. "Perry joins us at a time when we are increasing our focus on the clinical needs of our customers. He will play an integral role in ensuring that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.